Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pour

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Neoplasma|September 5, 2009
Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceL Kovarova, I Buresova, T Buchler, et al.
Vnitrni Lekarstvi|December 2, 2009
[IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review]Z Adam, J Feit, M Krejcí, et al.
Vnitrni Lekarstvi|February 21, 2009
[Treatment of Waldenström macroglobulinaemia--the experience of one centre]Z Adam, L Pour, M Krejcí, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow CytometryL Rihova, P Vsianska, R Bezdekova, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|February 12, 2025
Prophylactic osteosynthesis of long bones in patients with multiple myelomaV Nekuda, D Ira, M Štork, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 18, 2019
Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-UpM Stork, V Sandecká, I Boichuk, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|July 2, 2011
[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen]P Szturz, R Jakubcová, Z Adam, et al.
Neoplasma|June 27, 2018
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patientsM Stork, S Sevcikova, Z Adam, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|February 16, 2019
Plasma Cell Leukemia –  the Forgotten Dis­easeM Žárska, D Vrábel, R Bezdekova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 23, 2023
Waldenström's macroglobulinemia - clinical symptoms and review of therapy yesterday, today and tomorrowZ Adam, L Pour, D Zeman, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Neoplasma|September 5, 2009
Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceL Kovarova, I Buresova, T Buchler, et al.
Vnitrni Lekarstvi|December 2, 2009
[IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review]Z Adam, J Feit, M Krejcí, et al.
Vnitrni Lekarstvi|February 21, 2009
[Treatment of Waldenström macroglobulinaemia--the experience of one centre]Z Adam, L Pour, M Krejcí, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow CytometryL Rihova, P Vsianska, R Bezdekova, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|February 12, 2025
Prophylactic osteosynthesis of long bones in patients with multiple myelomaV Nekuda, D Ira, M Štork, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 18, 2019
Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-UpM Stork, V Sandecká, I Boichuk, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|July 2, 2011
[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen]P Szturz, R Jakubcová, Z Adam, et al.
Neoplasma|June 27, 2018
Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patientsM Stork, S Sevcikova, Z Adam, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|February 16, 2019
Plasma Cell Leukemia –  the Forgotten Dis­easeM Žárska, D Vrábel, R Bezdekova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 23, 2023
Waldenström's macroglobulinemia - clinical symptoms and review of therapy yesterday, today and tomorrowZ Adam, L Pour, D Zeman, et al.
Pageof 11